Drug Shortage Report for GABAPENTIN
Report ID | 33110 |
Drug Identification Number | 02353245 |
Brand name | GABAPENTIN |
Common or Proper name | GABAPENTIN CAP |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-11 |
Estimated end date | 2017-12-29 |
Actual end date | 2017-12-21 |
Shortage status | Resolved |
Updated date | 2017-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-12-22 | French | Compare |
v5 | 2017-12-22 | English | Compare |
v4 | 2017-12-15 | French | Compare |
v3 | 2017-12-15 | English | Compare |
v2 | 2017-12-15 | French | Compare |
v1 | 2017-12-15 | English | Compare |
Showing 1 to 6 of 6